Thrombolysis in patients with prior stroke within the last 3 months

European Journal of Neurology

Volumn 21, Issue 12, 2014, Pages 1493-1499

  Heldner, M R ^a   Mattle, H P ^a   Jung, S ^a   Fischer, U ^a   Gralla, J ^a   Zubler, C ^a   El Koussy, M ^a   Schroth, G ^a   Arnold, M ^a   Mono, M L ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute ischaemic stroke; Early recurrent stroke; Intravenous, endovascular and bridging thrombolysis; Stroke management

Indexed keywords

AGED; ARTICLE; BASILAR ARTERY; BASILAR ARTERY OBSTRUCTION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK BENEFIT ANALYSIS; RISK FACTOR; SCORING SYSTEM; ADVERSE EFFECTS; CEREBRAL HEMORRHAGE; FIBRINOLYTIC THERAPY; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; STROKE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84915823183     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12519     Document Type: Article

References (30)

1. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 14: 1317-1329.
3. Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004; 35: 1925-1929.
4. Ay H, Gungor L, Arsava EM, et al. A score to predict early risk of recurrence after ischemic stroke. Neurology 2010; 74: 128-135.
5. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
6. Ad Hoc Committee representing the National Stroke Foundation and the Stroke Society of Australasia. The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia. Intern Med J 2009; 39: 317-324.
7. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33: 1828-1833.
8. Fischer U, Mono ML, Zwahlen M, et al. Impact of thrombolysis on stroke outcome at 12 months in a population: the Bern stroke project. Stroke 2012; 43: 1039-1045.
9. Mono ML, Romagna L, Jung S, et al. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians. Cerebrovasc Dis 2012; 33: 116-122.
10. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126-131.
11. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 1994; 25: 2220-2226.
12. White JB, Cloft HJ, Kallmes DF, Manno EM. Expanding the treatment window with mechanical thrombectomy in acute ischemic stroke. Neuroradiology 2006; 48: 402-404.
13. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282: 2003-2011.
14. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
15. European Stroke Initiative Executive Committee, EUSI Writing Committee, Olsen TS, et al. European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc Dis 2003; 16: 311-337.
16. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007; 38: 1091-1096.
17. Wahlgreen N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282.
18. Hill MD, Buchan AM, Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005; 172: 1307-1312.
19. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
20. Aleu A, Mellado P, Lichy C, Köhrmann M, Schellinger PD. Hemorrhagic complications after off-label thrombolysis for ischemic stroke. Stroke 2007; 38: 417-422.
21. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurrú C, Biller J. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001; 32: 12-16.
22. Karliński M, Kobayashi A, Litwin T, et al. Intravenous thrombolysis for acute ischaemic stroke in patients not fully adhering to the European licence in Poland. Neurol Neurochir Pol 2012; 46: 3-14.
23. Karliński M, Mikulik R, Sanak D, Wahlgren N, Czlonkowska A, SITS-EAST Collaborative Group. Intravenous alteplase in ischemic stroke patients not fully adhering to the current drug license in Central and Eastern Europe. Int J Stroke 2012; 7: 615-622.
24. Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the Third International Stroke Trial (IST-3)): a randomized controlled trial. Lancet 2012; 379: 2352-2363.
25. Nguyen TH, Vo D, Ngo MB, et al. Thrombolysis in recurrent lacunar stroke: a case example. Eur J Neurol 2008; 15: 1409-1411.
26. Meretoja A, Putaala J, Tatlisumak T, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke 2010; 41: 1450-1458.
27. Alhazzaa M, Sharma M, Blacquiere D, Stotts G, Hogan M, Dowlathshahi D. Thrombolysis despite recent stroke. Stroke 2013; 44: 1736-1738.
28. Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapy. Stroke 2007; 38: 431-440.
29. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke 2012; 43: 2904-2909.
30. Álvarez-Sabín J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12: 689-705.